Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design.
J Pharm Biomed Anal
; 29(6): 1097-103, 2002 Aug 01.
Article
en En
| MEDLINE
| ID: mdl-12110395
A rapid and sensitive RP-HPLC method with UV detection for routine control of oxaliplatin in a pharmaceutical formulation (Eloxatin) was developed. Quantitation was accomplished with the internal standard method. The procedure was validated by linearity (correlation coefficient=0.999948), accuracy, robustness and intermediate precision. Experimental design was used during validation to calculate method robustness and intermediate precision. For robustness test three factors were considered: percentage v/v of acetonitrile, flow rate and temperature; an increase in the flow rate results in a decrease of the drug found concentration, while the percentage of organic modifier and temperature have no important effect on the response. For intermediate precision measure the considered variables were: analyst, equipment and days. The RSD value (2.27%, n=24) indicated a good precision of the analytical method.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Compuestos Organoplatinos
/
Cromatografía Líquida de Alta Presión
/
Antineoplásicos
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
J Pharm Biomed Anal
Año:
2002
Tipo del documento:
Article
País de afiliación:
Italia
Pais de publicación:
Reino Unido